Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Fukuda

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
Medicine|February 3, 2021
Safety and feasibility of laparoscopic gastrectomy for remnant gastric cancer compared with open gastrectomy: Single-center experienceJunya Kitadani, Toshiyasu Ojima, Masaki Nakamura, et al.
BMC Surgery|July 2, 2022
Nutritional benefit of remnant gastric preservation in patients with esophageal cancer undergoing radical esophagectomy and ileo-colon interpositionJunya Kitadani, Toshiyasu Ojima, Keiji Hayata, et al.
Surgical Endoscopy|February 19, 2022
Laparoscopic sleeve gastrectomy for morbid obesity improves gut microbiota balance, increases colonic mucosal-associated invariant T cells and decreases circulating regulatory T cellsNaoki Fukuda, Toshiyasu Ojima, Keiji Hayata, et al.
Endoscopy International Open|March 21, 2017
Mucosal breaks show same circumferential distribution in majority of patients with recurrent reflux esophagitisNaoki Fukuda, Norihisa Ishimura, Mayumi Okada, et al.
In Vivo (Athens, Greece)|February 24, 2021
Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck CancerYasuyoshi Sato, Naoki Fukuda, Y U Fujiwara, et al.
Cancer Management and Research|June 26, 2020
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 TrialYasuyoshi Sato, Naoki Fukuda, Xiaofei Wang, et al.
Endocrine Journal|January 31, 2024
Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinibNaoki Fukuda, Kazuhisa Toda, Hirotaka Suto, et al.
International Journal of Clinical Oncology|November 21, 2022
Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancerDaisaku Kamiimabeppu, Takeru Wakatsuki, Daisuke Takahari, et al.
Endocrine Journal|January 28, 2021
Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patientsNaoki Fukuda, Kazuhisa Toda, Xiaofei Wang, et al.
BMC Cancer|April 23, 2020
Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancerSadayuki Kawai, Naoki Fukuda, Shun Yamamoto, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Medicine|February 3, 2021
Safety and feasibility of laparoscopic gastrectomy for remnant gastric cancer compared with open gastrectomy: Single-center experienceJunya Kitadani, Toshiyasu Ojima, Masaki Nakamura, et al.
BMC Surgery|July 2, 2022
Nutritional benefit of remnant gastric preservation in patients with esophageal cancer undergoing radical esophagectomy and ileo-colon interpositionJunya Kitadani, Toshiyasu Ojima, Keiji Hayata, et al.
Surgical Endoscopy|February 19, 2022
Laparoscopic sleeve gastrectomy for morbid obesity improves gut microbiota balance, increases colonic mucosal-associated invariant T cells and decreases circulating regulatory T cellsNaoki Fukuda, Toshiyasu Ojima, Keiji Hayata, et al.
Endoscopy International Open|March 21, 2017
Mucosal breaks show same circumferential distribution in majority of patients with recurrent reflux esophagitisNaoki Fukuda, Norihisa Ishimura, Mayumi Okada, et al.
In Vivo (Athens, Greece)|February 24, 2021
Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck CancerYasuyoshi Sato, Naoki Fukuda, Y U Fujiwara, et al.
Cancer Management and Research|June 26, 2020
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 TrialYasuyoshi Sato, Naoki Fukuda, Xiaofei Wang, et al.
Endocrine Journal|January 31, 2024
Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinibNaoki Fukuda, Kazuhisa Toda, Hirotaka Suto, et al.
International Journal of Clinical Oncology|November 21, 2022
Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancerDaisaku Kamiimabeppu, Takeru Wakatsuki, Daisuke Takahari, et al.
Endocrine Journal|January 28, 2021
Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patientsNaoki Fukuda, Kazuhisa Toda, Xiaofei Wang, et al.
BMC Cancer|April 23, 2020
Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancerSadayuki Kawai, Naoki Fukuda, Shun Yamamoto, et al.
Pageof 11